Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.86 |
| ▸ | CXCL12 | P48061 | 2/20 | 0.86 |
| ▸ | MAOA | P21397 | 3/20 | 0.83 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.82 |
| ▸ | F3 | P13726 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.66 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4',4-Dichlorochalcone SCHEMBL659211 | 1.00 | MAOB (0.86) | MAOBCXCL12MAOACYP1B1F3 | |
| 4',4-Dichlorochalcone SCHEMBL11819608 | 0.98 | MAOB (0.83) | MAOBCXCL12MAOACYP1B1F3 | |
| 4',4-Dichlorochalcone SCHEMBL11819602 | 0.98 | MAOB (0.83) | MAOBCXCL12MAOACYP1B1F3 | |
| 4',4-Dichlorochalcone SCHEMBL11819262 | 0.98 | MAOB (0.83) | MAOBCXCL12MAOACYP1B1F3 | |
| 4',4-Dichlorochalcone SCHEMBL11819257 | 0.98 | MAOB (0.83) | MAOBCXCL12MAOACYP1B1F3 | |
| SCHEMBL25221687 | 0.93 | MAOB (1.00) | MAOBCXCL12MAOACYP1B1F3 | |
| SCHEMBL25202083 | 0.93 | MAOB (0.77) | MAOBCXCL12MAOACYP1B1F3 | |
| SCHEMBL11348184 | 0.93 | MAOB (1.00) | MAOBCXCL12MAOACYP1B1F3 | |
| SCHEMBL25190973 | 0.93 | MAOB (0.77) | MAOBCXCL12MAOACYP1B1F3 | |
| SCHEMBL11486409 | 0.93 | MAOB (0.77) | MAOBCXCL12MAOACYP1B1F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062385-A1 | ORGANIC COMPOUND | SEMICONDUCTOR ENERGY LAB (JP) | 2026-03-05 | — | — | US | disclosed |
| CN-115368268-B | Method for efficiently preparing azo compound and application thereof | 大连理工大学 | 2023-11-17 | — | — | CN | disclosed |
| US-11661407-B2 | Process for the preparation of pyrylium salts | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2023-05-30 | — | — | US | disclosed |
| CN-115368268-A | Method for efficiently preparing azo compound and application thereof | 大连理工大学 | 2022-11-22 | — | — | CN | disclosed |
| US-20210400997-A1 | APPLICATIONS OF DIPHENYLPROPENONE COMPOUND IN PREPARING ANIMAL FEED ADDITIVE OR ANIMAL FEED | PENG, Xianfeng (CN) | 2021-12-30 | — | — | US | disclosed |
| EP-3874964-A1 | APPLICATIONS OF DIPHENYLPROPENONE COMPOUND IN PREPARING ANIMAL FEED ADDITIVE OR ANIMAL FEED | Peng, Xianfeng (CN) | 2021-09-08 | — | — | EP | disclosed |
| US-20210087158-A1 | A PROCESS FOR THE PREPARATION OF PYRYLIUM SALTS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-03-25 | — | — | US | disclosed |
| EP-2349999-B1 | ALLOSTERIC PROTEIN KINASE MODULATORS | UNIV SAARLAND (DE) | 2016-01-27 | — | — | EP | disclosed |
| US-8912186-B2 | Allosteric protein kinase modulators | UNIVERSITAET DES SAARLANDES (DE) | 2014-12-16 | — | — | US | disclosed |
| US-20120046307-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | UNIVERSITAET DES SAARLANDES (DE) | 2012-02-23 | — | — | US | disclosed |
| US-5360935-A | From phenylmethanesulfonyl fluorides and phenylacyl bromides, phase transfer agent, base, solvent | NIHON BAYER AGROCHEM K.K. (JP) | 1994-11-01 | — | — | US | disclosed |
| EP-0540604-A1 | SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B 4? ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS | Aventis Pharma S.A. (FR) | 1993-05-12 | — | — | EP | disclosed |
| EP-0534249-A2 | Process for the preparation of 3-phenyl-2-propenones | NIHON BAYER AGROCHEM K.K. (JP) | 1993-03-31 | — | — | EP | disclosed |
| WO-1992001675-A2 | SUBSTITUTED BICYCLIC BIS-ARYL COMPOUNDS EXHIBITING SELECTIVE LEUKOTRIENE B4 ANTAGONIST ACTIVITY, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS | RHONE-POULENC RORER S.A. (FR) | 1992-02-06 | — | — | WO | disclosed |
| US-4584008-A | FUNGICIDES AND PLANT GROWTH REGULATORS | CHEVRON RESEARCH COMPANY (US) | 1986-04-22 | — | — | US | disclosed |
| EP-0102163-A1 | Triazole derivatives and compositions containing the same | CHEVRON RESEARCH COMPANY (US) | 1984-03-07 | — | — | EP | disclosed |
| US-4095026-A | PYRAZOLINE COMPOUNDS HAVING INSECTICIDAL ACTIVITY | U.S. PHILIPS CORPORATION (US) | 1978-06-13 | — | — | US | disclosed |
| US-4010271-A | NOVEL PYRAZOLINE COMPOUNDS HAVING INSECTICIDAL ACTIVITY | U.S. PHILIPS CORPORATION (US) | 1977-03-01 | — | — | US | disclosed |
| US-3991073-A | Pyrazoline compounds having insecticidal activity | U.S. PHILIPS CORPORATION (US) | 1976-11-09 | — | — | US | disclosed |
| US-3931152-A | ANTITUBERCULAR | AMERICAN CYANAMID COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210087158-A1 | A PROCESS FOR THE PREPARATION OF PYRYLIUM SALTS | IPO5, SF3B5, CYP4F11 | MAOB 2307/4885CXCL12 3140/4885MAOA 3394/4885 |
| US-20260062385-A1 | ORGANIC COMPOUND | LAS1L, CCNL2, CCNA1 | MAOB 1885/4885CXCL12 1195/4885MAOA 2046/4885 |
| US-20120046307-A1 | ALLOSTERIC PROTEIN KINASE MODULATORS | AURKC, AURKA, AURKB | MAOB 4512/4885CXCL12 3504/4885MAOA 4177/4885 |
| US-11661407-B2 | Process for the preparation of pyrylium salts | SF3B5, IPO5, CYP4F11 | MAOB 2613/4885CXCL12 3354/4885MAOA 3764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.